Large placebo effect seen in trial of maralixibat for primary biliary cholangitis

BARCELONA – An international phase II trial with the investigational bile acid transporter inhibitor maralixibat chloride failed to meet its primary endpoint of reducing the weekly itch score to a...
Source: Family Practice News - Category: Primary Care Source Type: news